Advisory Board March 25, 2025
According to new CDC data, flu activity across the United States has declined significantly in recent weeks but remains elevated in several areas. Meanwhile, FDA has issued new flu vaccine recommendations for 2025-2026 after cancelling a meeting of its vaccine advisory committee.
5 considerations before implementing multi-viral point-of-care testing in EDs
Flu activity declines but remains elevated
For the week ending March 15, the flu test positivity rate was 13.2%. Meanwhile, the COVID-19 test positivity rate was 3.4%, and the respiratory syncytial virus (RSV) test positivity rate was 5.5%.
Although flu rates have declined steadily over the last few weeks, several parts of the country are still reporting significant flu activity.
Across the United States, 20 jurisdictions reported “high”...
Today's Sponsors
Today's Sponsor